Carrageenans from the Red Seaweed <i<Sarconema filiforme</i< Attenuate Symptoms of Diet-Induced Metabolic Syndrome in Rats
Carrageenans are thickening and gelling agents that may provide health benefits. Iota (ι)-carrageenan, a linear sulfated polysaccharide, is produced by the red seaweed, <i<Sarconema filiforme</i<. This study investigated the potential of this seaweed as a functional food for the reversal...
Ausführliche Beschreibung
Autor*in: |
Ryan du Preez [verfasserIn] Nicholas Paul [verfasserIn] Peter Mouatt [verfasserIn] Marwan E. Majzoub [verfasserIn] Torsten Thomas [verfasserIn] Sunil K. Panchal [verfasserIn] Lindsay Brown [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2020 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
In: Marine Drugs - MDPI AG, 2005, 18(2020), 2, p 97 |
---|---|
Übergeordnetes Werk: |
volume:18 ; year:2020 ; number:2, p 97 |
Links: |
---|
DOI / URN: |
10.3390/md18020097 |
---|
Katalog-ID: |
DOAJ086577522 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ086577522 | ||
003 | DE-627 | ||
005 | 20230311051921.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230311s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/md18020097 |2 doi | |
035 | |a (DE-627)DOAJ086577522 | ||
035 | |a (DE-599)DOAJ8926b0591a054c76b0c309b8996523c0 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a QH301-705.5 | |
100 | 0 | |a Ryan du Preez |e verfasserin |4 aut | |
245 | 1 | 0 | |a Carrageenans from the Red Seaweed <i<Sarconema filiforme</i< Attenuate Symptoms of Diet-Induced Metabolic Syndrome in Rats |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Carrageenans are thickening and gelling agents that may provide health benefits. Iota (ι)-carrageenan, a linear sulfated polysaccharide, is produced by the red seaweed, <i<Sarconema filiforme</i<. This study investigated the potential of this seaweed as a functional food for the reversal of metabolic syndrome and possible mechanisms. Male Wistar rats were divided into four groups in a 16-week protocol: corn starch diet-fed rats (C); C rats supplemented with 5% <i<S. filiforme</i< for the last 8 weeks (CSF); high-carbohydrate, high-fat diet-fed rats (H); and H rats supplemented with 5% <i<S. filiforme</i< for the last 8 weeks (HSF). <i<S. filiforme</i< was produced in tank-based aquaculture yielding 27 g dry weight/day/m<sup<2</sup< of culture area. H rats developed obesity, hypertension, dyslipidaemia, glucose intolerance, fatty liver and increased left ventricular collagen deposition. <i<S. filiforme</i< supplementation decreased body weight, abdominal and liver fat, systolic blood pressure, plasma total cholesterol concentrations, and plasma activities of alanine transaminase and aspartate transaminase. <i<S. filiforme</i< supplementation modulated gut microbiota without changing the Firmicutes to Bacteroidetes ratio. <i<S. filiforme</i< improved symptoms of high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. Possible mechanisms include a reduced infiltration of inflammatory cells into organs as well as prebiotic actions in the gastrointestinal tract. | ||
650 | 4 | |a algae | |
650 | 4 | |a <i<sarconema filiforme</i< | |
650 | 4 | |a sulfated polysaccharides | |
650 | 4 | |a <i<ι</i<-carrageenan | |
650 | 4 | |a prebiotics | |
650 | 4 | |a gut microbiota | |
650 | 4 | |a aquaculture | |
650 | 4 | |a nutraceutical | |
653 | 0 | |a Biology (General) | |
700 | 0 | |a Nicholas Paul |e verfasserin |4 aut | |
700 | 0 | |a Peter Mouatt |e verfasserin |4 aut | |
700 | 0 | |a Marwan E. Majzoub |e verfasserin |4 aut | |
700 | 0 | |a Torsten Thomas |e verfasserin |4 aut | |
700 | 0 | |a Sunil K. Panchal |e verfasserin |4 aut | |
700 | 0 | |a Lindsay Brown |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Marine Drugs |d MDPI AG, 2005 |g 18(2020), 2, p 97 |w (DE-627)477992420 |w (DE-600)2175190-0 |x 16603397 |7 nnns |
773 | 1 | 8 | |g volume:18 |g year:2020 |g number:2, p 97 |
856 | 4 | 0 | |u https://doi.org/10.3390/md18020097 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/8926b0591a054c76b0c309b8996523c0 |z kostenfrei |
856 | 4 | 0 | |u https://www.mdpi.com/1660-3397/18/2/97 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1660-3397 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_70 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_381 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_2147 | ||
912 | |a GBV_ILN_2148 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 18 |j 2020 |e 2, p 97 |
author_variant |
r d p rdp n p np p m pm m e m mem t t tt s k p skp l b lb |
---|---|
matchkey_str |
article:16603397:2020----::argeasrmhrdeweiacnmflfreatnaeyposfitn |
hierarchy_sort_str |
2020 |
callnumber-subject-code |
QH |
publishDate |
2020 |
allfields |
10.3390/md18020097 doi (DE-627)DOAJ086577522 (DE-599)DOAJ8926b0591a054c76b0c309b8996523c0 DE-627 ger DE-627 rakwb eng QH301-705.5 Ryan du Preez verfasserin aut Carrageenans from the Red Seaweed <i<Sarconema filiforme</i< Attenuate Symptoms of Diet-Induced Metabolic Syndrome in Rats 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Carrageenans are thickening and gelling agents that may provide health benefits. Iota (ι)-carrageenan, a linear sulfated polysaccharide, is produced by the red seaweed, <i<Sarconema filiforme</i<. This study investigated the potential of this seaweed as a functional food for the reversal of metabolic syndrome and possible mechanisms. Male Wistar rats were divided into four groups in a 16-week protocol: corn starch diet-fed rats (C); C rats supplemented with 5% <i<S. filiforme</i< for the last 8 weeks (CSF); high-carbohydrate, high-fat diet-fed rats (H); and H rats supplemented with 5% <i<S. filiforme</i< for the last 8 weeks (HSF). <i<S. filiforme</i< was produced in tank-based aquaculture yielding 27 g dry weight/day/m<sup<2</sup< of culture area. H rats developed obesity, hypertension, dyslipidaemia, glucose intolerance, fatty liver and increased left ventricular collagen deposition. <i<S. filiforme</i< supplementation decreased body weight, abdominal and liver fat, systolic blood pressure, plasma total cholesterol concentrations, and plasma activities of alanine transaminase and aspartate transaminase. <i<S. filiforme</i< supplementation modulated gut microbiota without changing the Firmicutes to Bacteroidetes ratio. <i<S. filiforme</i< improved symptoms of high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. Possible mechanisms include a reduced infiltration of inflammatory cells into organs as well as prebiotic actions in the gastrointestinal tract. algae <i<sarconema filiforme</i< sulfated polysaccharides <i<ι</i<-carrageenan prebiotics gut microbiota aquaculture nutraceutical Biology (General) Nicholas Paul verfasserin aut Peter Mouatt verfasserin aut Marwan E. Majzoub verfasserin aut Torsten Thomas verfasserin aut Sunil K. Panchal verfasserin aut Lindsay Brown verfasserin aut In Marine Drugs MDPI AG, 2005 18(2020), 2, p 97 (DE-627)477992420 (DE-600)2175190-0 16603397 nnns volume:18 year:2020 number:2, p 97 https://doi.org/10.3390/md18020097 kostenfrei https://doaj.org/article/8926b0591a054c76b0c309b8996523c0 kostenfrei https://www.mdpi.com/1660-3397/18/2/97 kostenfrei https://doaj.org/toc/1660-3397 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_381 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 18 2020 2, p 97 |
spelling |
10.3390/md18020097 doi (DE-627)DOAJ086577522 (DE-599)DOAJ8926b0591a054c76b0c309b8996523c0 DE-627 ger DE-627 rakwb eng QH301-705.5 Ryan du Preez verfasserin aut Carrageenans from the Red Seaweed <i<Sarconema filiforme</i< Attenuate Symptoms of Diet-Induced Metabolic Syndrome in Rats 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Carrageenans are thickening and gelling agents that may provide health benefits. Iota (ι)-carrageenan, a linear sulfated polysaccharide, is produced by the red seaweed, <i<Sarconema filiforme</i<. This study investigated the potential of this seaweed as a functional food for the reversal of metabolic syndrome and possible mechanisms. Male Wistar rats were divided into four groups in a 16-week protocol: corn starch diet-fed rats (C); C rats supplemented with 5% <i<S. filiforme</i< for the last 8 weeks (CSF); high-carbohydrate, high-fat diet-fed rats (H); and H rats supplemented with 5% <i<S. filiforme</i< for the last 8 weeks (HSF). <i<S. filiforme</i< was produced in tank-based aquaculture yielding 27 g dry weight/day/m<sup<2</sup< of culture area. H rats developed obesity, hypertension, dyslipidaemia, glucose intolerance, fatty liver and increased left ventricular collagen deposition. <i<S. filiforme</i< supplementation decreased body weight, abdominal and liver fat, systolic blood pressure, plasma total cholesterol concentrations, and plasma activities of alanine transaminase and aspartate transaminase. <i<S. filiforme</i< supplementation modulated gut microbiota without changing the Firmicutes to Bacteroidetes ratio. <i<S. filiforme</i< improved symptoms of high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. Possible mechanisms include a reduced infiltration of inflammatory cells into organs as well as prebiotic actions in the gastrointestinal tract. algae <i<sarconema filiforme</i< sulfated polysaccharides <i<ι</i<-carrageenan prebiotics gut microbiota aquaculture nutraceutical Biology (General) Nicholas Paul verfasserin aut Peter Mouatt verfasserin aut Marwan E. Majzoub verfasserin aut Torsten Thomas verfasserin aut Sunil K. Panchal verfasserin aut Lindsay Brown verfasserin aut In Marine Drugs MDPI AG, 2005 18(2020), 2, p 97 (DE-627)477992420 (DE-600)2175190-0 16603397 nnns volume:18 year:2020 number:2, p 97 https://doi.org/10.3390/md18020097 kostenfrei https://doaj.org/article/8926b0591a054c76b0c309b8996523c0 kostenfrei https://www.mdpi.com/1660-3397/18/2/97 kostenfrei https://doaj.org/toc/1660-3397 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_381 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 18 2020 2, p 97 |
allfields_unstemmed |
10.3390/md18020097 doi (DE-627)DOAJ086577522 (DE-599)DOAJ8926b0591a054c76b0c309b8996523c0 DE-627 ger DE-627 rakwb eng QH301-705.5 Ryan du Preez verfasserin aut Carrageenans from the Red Seaweed <i<Sarconema filiforme</i< Attenuate Symptoms of Diet-Induced Metabolic Syndrome in Rats 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Carrageenans are thickening and gelling agents that may provide health benefits. Iota (ι)-carrageenan, a linear sulfated polysaccharide, is produced by the red seaweed, <i<Sarconema filiforme</i<. This study investigated the potential of this seaweed as a functional food for the reversal of metabolic syndrome and possible mechanisms. Male Wistar rats were divided into four groups in a 16-week protocol: corn starch diet-fed rats (C); C rats supplemented with 5% <i<S. filiforme</i< for the last 8 weeks (CSF); high-carbohydrate, high-fat diet-fed rats (H); and H rats supplemented with 5% <i<S. filiforme</i< for the last 8 weeks (HSF). <i<S. filiforme</i< was produced in tank-based aquaculture yielding 27 g dry weight/day/m<sup<2</sup< of culture area. H rats developed obesity, hypertension, dyslipidaemia, glucose intolerance, fatty liver and increased left ventricular collagen deposition. <i<S. filiforme</i< supplementation decreased body weight, abdominal and liver fat, systolic blood pressure, plasma total cholesterol concentrations, and plasma activities of alanine transaminase and aspartate transaminase. <i<S. filiforme</i< supplementation modulated gut microbiota without changing the Firmicutes to Bacteroidetes ratio. <i<S. filiforme</i< improved symptoms of high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. Possible mechanisms include a reduced infiltration of inflammatory cells into organs as well as prebiotic actions in the gastrointestinal tract. algae <i<sarconema filiforme</i< sulfated polysaccharides <i<ι</i<-carrageenan prebiotics gut microbiota aquaculture nutraceutical Biology (General) Nicholas Paul verfasserin aut Peter Mouatt verfasserin aut Marwan E. Majzoub verfasserin aut Torsten Thomas verfasserin aut Sunil K. Panchal verfasserin aut Lindsay Brown verfasserin aut In Marine Drugs MDPI AG, 2005 18(2020), 2, p 97 (DE-627)477992420 (DE-600)2175190-0 16603397 nnns volume:18 year:2020 number:2, p 97 https://doi.org/10.3390/md18020097 kostenfrei https://doaj.org/article/8926b0591a054c76b0c309b8996523c0 kostenfrei https://www.mdpi.com/1660-3397/18/2/97 kostenfrei https://doaj.org/toc/1660-3397 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_381 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 18 2020 2, p 97 |
allfieldsGer |
10.3390/md18020097 doi (DE-627)DOAJ086577522 (DE-599)DOAJ8926b0591a054c76b0c309b8996523c0 DE-627 ger DE-627 rakwb eng QH301-705.5 Ryan du Preez verfasserin aut Carrageenans from the Red Seaweed <i<Sarconema filiforme</i< Attenuate Symptoms of Diet-Induced Metabolic Syndrome in Rats 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Carrageenans are thickening and gelling agents that may provide health benefits. Iota (ι)-carrageenan, a linear sulfated polysaccharide, is produced by the red seaweed, <i<Sarconema filiforme</i<. This study investigated the potential of this seaweed as a functional food for the reversal of metabolic syndrome and possible mechanisms. Male Wistar rats were divided into four groups in a 16-week protocol: corn starch diet-fed rats (C); C rats supplemented with 5% <i<S. filiforme</i< for the last 8 weeks (CSF); high-carbohydrate, high-fat diet-fed rats (H); and H rats supplemented with 5% <i<S. filiforme</i< for the last 8 weeks (HSF). <i<S. filiforme</i< was produced in tank-based aquaculture yielding 27 g dry weight/day/m<sup<2</sup< of culture area. H rats developed obesity, hypertension, dyslipidaemia, glucose intolerance, fatty liver and increased left ventricular collagen deposition. <i<S. filiforme</i< supplementation decreased body weight, abdominal and liver fat, systolic blood pressure, plasma total cholesterol concentrations, and plasma activities of alanine transaminase and aspartate transaminase. <i<S. filiforme</i< supplementation modulated gut microbiota without changing the Firmicutes to Bacteroidetes ratio. <i<S. filiforme</i< improved symptoms of high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. Possible mechanisms include a reduced infiltration of inflammatory cells into organs as well as prebiotic actions in the gastrointestinal tract. algae <i<sarconema filiforme</i< sulfated polysaccharides <i<ι</i<-carrageenan prebiotics gut microbiota aquaculture nutraceutical Biology (General) Nicholas Paul verfasserin aut Peter Mouatt verfasserin aut Marwan E. Majzoub verfasserin aut Torsten Thomas verfasserin aut Sunil K. Panchal verfasserin aut Lindsay Brown verfasserin aut In Marine Drugs MDPI AG, 2005 18(2020), 2, p 97 (DE-627)477992420 (DE-600)2175190-0 16603397 nnns volume:18 year:2020 number:2, p 97 https://doi.org/10.3390/md18020097 kostenfrei https://doaj.org/article/8926b0591a054c76b0c309b8996523c0 kostenfrei https://www.mdpi.com/1660-3397/18/2/97 kostenfrei https://doaj.org/toc/1660-3397 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_381 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 18 2020 2, p 97 |
allfieldsSound |
10.3390/md18020097 doi (DE-627)DOAJ086577522 (DE-599)DOAJ8926b0591a054c76b0c309b8996523c0 DE-627 ger DE-627 rakwb eng QH301-705.5 Ryan du Preez verfasserin aut Carrageenans from the Red Seaweed <i<Sarconema filiforme</i< Attenuate Symptoms of Diet-Induced Metabolic Syndrome in Rats 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Carrageenans are thickening and gelling agents that may provide health benefits. Iota (ι)-carrageenan, a linear sulfated polysaccharide, is produced by the red seaweed, <i<Sarconema filiforme</i<. This study investigated the potential of this seaweed as a functional food for the reversal of metabolic syndrome and possible mechanisms. Male Wistar rats were divided into four groups in a 16-week protocol: corn starch diet-fed rats (C); C rats supplemented with 5% <i<S. filiforme</i< for the last 8 weeks (CSF); high-carbohydrate, high-fat diet-fed rats (H); and H rats supplemented with 5% <i<S. filiforme</i< for the last 8 weeks (HSF). <i<S. filiforme</i< was produced in tank-based aquaculture yielding 27 g dry weight/day/m<sup<2</sup< of culture area. H rats developed obesity, hypertension, dyslipidaemia, glucose intolerance, fatty liver and increased left ventricular collagen deposition. <i<S. filiforme</i< supplementation decreased body weight, abdominal and liver fat, systolic blood pressure, plasma total cholesterol concentrations, and plasma activities of alanine transaminase and aspartate transaminase. <i<S. filiforme</i< supplementation modulated gut microbiota without changing the Firmicutes to Bacteroidetes ratio. <i<S. filiforme</i< improved symptoms of high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. Possible mechanisms include a reduced infiltration of inflammatory cells into organs as well as prebiotic actions in the gastrointestinal tract. algae <i<sarconema filiforme</i< sulfated polysaccharides <i<ι</i<-carrageenan prebiotics gut microbiota aquaculture nutraceutical Biology (General) Nicholas Paul verfasserin aut Peter Mouatt verfasserin aut Marwan E. Majzoub verfasserin aut Torsten Thomas verfasserin aut Sunil K. Panchal verfasserin aut Lindsay Brown verfasserin aut In Marine Drugs MDPI AG, 2005 18(2020), 2, p 97 (DE-627)477992420 (DE-600)2175190-0 16603397 nnns volume:18 year:2020 number:2, p 97 https://doi.org/10.3390/md18020097 kostenfrei https://doaj.org/article/8926b0591a054c76b0c309b8996523c0 kostenfrei https://www.mdpi.com/1660-3397/18/2/97 kostenfrei https://doaj.org/toc/1660-3397 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_381 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 18 2020 2, p 97 |
language |
English |
source |
In Marine Drugs 18(2020), 2, p 97 volume:18 year:2020 number:2, p 97 |
sourceStr |
In Marine Drugs 18(2020), 2, p 97 volume:18 year:2020 number:2, p 97 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
algae <i<sarconema filiforme</i< sulfated polysaccharides <i<ι</i<-carrageenan prebiotics gut microbiota aquaculture nutraceutical Biology (General) |
isfreeaccess_bool |
true |
container_title |
Marine Drugs |
authorswithroles_txt_mv |
Ryan du Preez @@aut@@ Nicholas Paul @@aut@@ Peter Mouatt @@aut@@ Marwan E. Majzoub @@aut@@ Torsten Thomas @@aut@@ Sunil K. Panchal @@aut@@ Lindsay Brown @@aut@@ |
publishDateDaySort_date |
2020-01-01T00:00:00Z |
hierarchy_top_id |
477992420 |
id |
DOAJ086577522 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ086577522</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230311051921.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230311s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/md18020097</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ086577522</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ8926b0591a054c76b0c309b8996523c0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QH301-705.5</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Ryan du Preez</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Carrageenans from the Red Seaweed <i<Sarconema filiforme</i< Attenuate Symptoms of Diet-Induced Metabolic Syndrome in Rats</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Carrageenans are thickening and gelling agents that may provide health benefits. Iota (ι)-carrageenan, a linear sulfated polysaccharide, is produced by the red seaweed, <i<Sarconema filiforme</i<. This study investigated the potential of this seaweed as a functional food for the reversal of metabolic syndrome and possible mechanisms. Male Wistar rats were divided into four groups in a 16-week protocol: corn starch diet-fed rats (C); C rats supplemented with 5% <i<S. filiforme</i< for the last 8 weeks (CSF); high-carbohydrate, high-fat diet-fed rats (H); and H rats supplemented with 5% <i<S. filiforme</i< for the last 8 weeks (HSF). <i<S. filiforme</i< was produced in tank-based aquaculture yielding 27 g dry weight/day/m<sup<2</sup< of culture area. H rats developed obesity, hypertension, dyslipidaemia, glucose intolerance, fatty liver and increased left ventricular collagen deposition. <i<S. filiforme</i< supplementation decreased body weight, abdominal and liver fat, systolic blood pressure, plasma total cholesterol concentrations, and plasma activities of alanine transaminase and aspartate transaminase. <i<S. filiforme</i< supplementation modulated gut microbiota without changing the Firmicutes to Bacteroidetes ratio. <i<S. filiforme</i< improved symptoms of high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. Possible mechanisms include a reduced infiltration of inflammatory cells into organs as well as prebiotic actions in the gastrointestinal tract.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">algae</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a"><i<sarconema filiforme</i<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">sulfated polysaccharides</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a"><i<ι</i<-carrageenan</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">prebiotics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">gut microbiota</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">aquaculture</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">nutraceutical</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Biology (General)</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Nicholas Paul</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Peter Mouatt</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Marwan E. Majzoub</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Torsten Thomas</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sunil K. Panchal</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Lindsay Brown</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Marine Drugs</subfield><subfield code="d">MDPI AG, 2005</subfield><subfield code="g">18(2020), 2, p 97</subfield><subfield code="w">(DE-627)477992420</subfield><subfield code="w">(DE-600)2175190-0</subfield><subfield code="x">16603397</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:18</subfield><subfield code="g">year:2020</subfield><subfield code="g">number:2, p 97</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3390/md18020097</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/8926b0591a054c76b0c309b8996523c0</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.mdpi.com/1660-3397/18/2/97</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1660-3397</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_381</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2147</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2148</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">18</subfield><subfield code="j">2020</subfield><subfield code="e">2, p 97</subfield></datafield></record></collection>
|
callnumber-first |
Q - Science |
author |
Ryan du Preez |
spellingShingle |
Ryan du Preez misc QH301-705.5 misc algae misc <i<sarconema filiforme</i< misc sulfated polysaccharides misc <i<ι</i<-carrageenan misc prebiotics misc gut microbiota misc aquaculture misc nutraceutical misc Biology (General) Carrageenans from the Red Seaweed <i<Sarconema filiforme</i< Attenuate Symptoms of Diet-Induced Metabolic Syndrome in Rats |
authorStr |
Ryan du Preez |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)477992420 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
QH301-705 |
illustrated |
Not Illustrated |
issn |
16603397 |
topic_title |
QH301-705.5 Carrageenans from the Red Seaweed <i<Sarconema filiforme</i< Attenuate Symptoms of Diet-Induced Metabolic Syndrome in Rats algae <i<sarconema filiforme</i< sulfated polysaccharides <i<ι</i<-carrageenan prebiotics gut microbiota aquaculture nutraceutical |
topic |
misc QH301-705.5 misc algae misc <i<sarconema filiforme</i< misc sulfated polysaccharides misc <i<ι</i<-carrageenan misc prebiotics misc gut microbiota misc aquaculture misc nutraceutical misc Biology (General) |
topic_unstemmed |
misc QH301-705.5 misc algae misc <i<sarconema filiforme</i< misc sulfated polysaccharides misc <i<ι</i<-carrageenan misc prebiotics misc gut microbiota misc aquaculture misc nutraceutical misc Biology (General) |
topic_browse |
misc QH301-705.5 misc algae misc <i<sarconema filiforme</i< misc sulfated polysaccharides misc <i<ι</i<-carrageenan misc prebiotics misc gut microbiota misc aquaculture misc nutraceutical misc Biology (General) |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Marine Drugs |
hierarchy_parent_id |
477992420 |
hierarchy_top_title |
Marine Drugs |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)477992420 (DE-600)2175190-0 |
title |
Carrageenans from the Red Seaweed <i<Sarconema filiforme</i< Attenuate Symptoms of Diet-Induced Metabolic Syndrome in Rats |
ctrlnum |
(DE-627)DOAJ086577522 (DE-599)DOAJ8926b0591a054c76b0c309b8996523c0 |
title_full |
Carrageenans from the Red Seaweed <i<Sarconema filiforme</i< Attenuate Symptoms of Diet-Induced Metabolic Syndrome in Rats |
author_sort |
Ryan du Preez |
journal |
Marine Drugs |
journalStr |
Marine Drugs |
callnumber-first-code |
Q |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2020 |
contenttype_str_mv |
txt |
author_browse |
Ryan du Preez Nicholas Paul Peter Mouatt Marwan E. Majzoub Torsten Thomas Sunil K. Panchal Lindsay Brown |
container_volume |
18 |
class |
QH301-705.5 |
format_se |
Elektronische Aufsätze |
author-letter |
Ryan du Preez |
doi_str_mv |
10.3390/md18020097 |
author2-role |
verfasserin |
title_sort |
carrageenans from the red seaweed <i<sarconema filiforme</i< attenuate symptoms of diet-induced metabolic syndrome in rats |
callnumber |
QH301-705.5 |
title_auth |
Carrageenans from the Red Seaweed <i<Sarconema filiforme</i< Attenuate Symptoms of Diet-Induced Metabolic Syndrome in Rats |
abstract |
Carrageenans are thickening and gelling agents that may provide health benefits. Iota (ι)-carrageenan, a linear sulfated polysaccharide, is produced by the red seaweed, <i<Sarconema filiforme</i<. This study investigated the potential of this seaweed as a functional food for the reversal of metabolic syndrome and possible mechanisms. Male Wistar rats were divided into four groups in a 16-week protocol: corn starch diet-fed rats (C); C rats supplemented with 5% <i<S. filiforme</i< for the last 8 weeks (CSF); high-carbohydrate, high-fat diet-fed rats (H); and H rats supplemented with 5% <i<S. filiforme</i< for the last 8 weeks (HSF). <i<S. filiforme</i< was produced in tank-based aquaculture yielding 27 g dry weight/day/m<sup<2</sup< of culture area. H rats developed obesity, hypertension, dyslipidaemia, glucose intolerance, fatty liver and increased left ventricular collagen deposition. <i<S. filiforme</i< supplementation decreased body weight, abdominal and liver fat, systolic blood pressure, plasma total cholesterol concentrations, and plasma activities of alanine transaminase and aspartate transaminase. <i<S. filiforme</i< supplementation modulated gut microbiota without changing the Firmicutes to Bacteroidetes ratio. <i<S. filiforme</i< improved symptoms of high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. Possible mechanisms include a reduced infiltration of inflammatory cells into organs as well as prebiotic actions in the gastrointestinal tract. |
abstractGer |
Carrageenans are thickening and gelling agents that may provide health benefits. Iota (ι)-carrageenan, a linear sulfated polysaccharide, is produced by the red seaweed, <i<Sarconema filiforme</i<. This study investigated the potential of this seaweed as a functional food for the reversal of metabolic syndrome and possible mechanisms. Male Wistar rats were divided into four groups in a 16-week protocol: corn starch diet-fed rats (C); C rats supplemented with 5% <i<S. filiforme</i< for the last 8 weeks (CSF); high-carbohydrate, high-fat diet-fed rats (H); and H rats supplemented with 5% <i<S. filiforme</i< for the last 8 weeks (HSF). <i<S. filiforme</i< was produced in tank-based aquaculture yielding 27 g dry weight/day/m<sup<2</sup< of culture area. H rats developed obesity, hypertension, dyslipidaemia, glucose intolerance, fatty liver and increased left ventricular collagen deposition. <i<S. filiforme</i< supplementation decreased body weight, abdominal and liver fat, systolic blood pressure, plasma total cholesterol concentrations, and plasma activities of alanine transaminase and aspartate transaminase. <i<S. filiforme</i< supplementation modulated gut microbiota without changing the Firmicutes to Bacteroidetes ratio. <i<S. filiforme</i< improved symptoms of high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. Possible mechanisms include a reduced infiltration of inflammatory cells into organs as well as prebiotic actions in the gastrointestinal tract. |
abstract_unstemmed |
Carrageenans are thickening and gelling agents that may provide health benefits. Iota (ι)-carrageenan, a linear sulfated polysaccharide, is produced by the red seaweed, <i<Sarconema filiforme</i<. This study investigated the potential of this seaweed as a functional food for the reversal of metabolic syndrome and possible mechanisms. Male Wistar rats were divided into four groups in a 16-week protocol: corn starch diet-fed rats (C); C rats supplemented with 5% <i<S. filiforme</i< for the last 8 weeks (CSF); high-carbohydrate, high-fat diet-fed rats (H); and H rats supplemented with 5% <i<S. filiforme</i< for the last 8 weeks (HSF). <i<S. filiforme</i< was produced in tank-based aquaculture yielding 27 g dry weight/day/m<sup<2</sup< of culture area. H rats developed obesity, hypertension, dyslipidaemia, glucose intolerance, fatty liver and increased left ventricular collagen deposition. <i<S. filiforme</i< supplementation decreased body weight, abdominal and liver fat, systolic blood pressure, plasma total cholesterol concentrations, and plasma activities of alanine transaminase and aspartate transaminase. <i<S. filiforme</i< supplementation modulated gut microbiota without changing the Firmicutes to Bacteroidetes ratio. <i<S. filiforme</i< improved symptoms of high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. Possible mechanisms include a reduced infiltration of inflammatory cells into organs as well as prebiotic actions in the gastrointestinal tract. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_381 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
2, p 97 |
title_short |
Carrageenans from the Red Seaweed <i<Sarconema filiforme</i< Attenuate Symptoms of Diet-Induced Metabolic Syndrome in Rats |
url |
https://doi.org/10.3390/md18020097 https://doaj.org/article/8926b0591a054c76b0c309b8996523c0 https://www.mdpi.com/1660-3397/18/2/97 https://doaj.org/toc/1660-3397 |
remote_bool |
true |
author2 |
Nicholas Paul Peter Mouatt Marwan E. Majzoub Torsten Thomas Sunil K. Panchal Lindsay Brown |
author2Str |
Nicholas Paul Peter Mouatt Marwan E. Majzoub Torsten Thomas Sunil K. Panchal Lindsay Brown |
ppnlink |
477992420 |
callnumber-subject |
QH - Natural History and Biology |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.3390/md18020097 |
callnumber-a |
QH301-705.5 |
up_date |
2024-07-03T21:30:57.579Z |
_version_ |
1803595030284206080 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ086577522</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230311051921.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230311s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/md18020097</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ086577522</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ8926b0591a054c76b0c309b8996523c0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QH301-705.5</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Ryan du Preez</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Carrageenans from the Red Seaweed <i<Sarconema filiforme</i< Attenuate Symptoms of Diet-Induced Metabolic Syndrome in Rats</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Carrageenans are thickening and gelling agents that may provide health benefits. Iota (ι)-carrageenan, a linear sulfated polysaccharide, is produced by the red seaweed, <i<Sarconema filiforme</i<. This study investigated the potential of this seaweed as a functional food for the reversal of metabolic syndrome and possible mechanisms. Male Wistar rats were divided into four groups in a 16-week protocol: corn starch diet-fed rats (C); C rats supplemented with 5% <i<S. filiforme</i< for the last 8 weeks (CSF); high-carbohydrate, high-fat diet-fed rats (H); and H rats supplemented with 5% <i<S. filiforme</i< for the last 8 weeks (HSF). <i<S. filiforme</i< was produced in tank-based aquaculture yielding 27 g dry weight/day/m<sup<2</sup< of culture area. H rats developed obesity, hypertension, dyslipidaemia, glucose intolerance, fatty liver and increased left ventricular collagen deposition. <i<S. filiforme</i< supplementation decreased body weight, abdominal and liver fat, systolic blood pressure, plasma total cholesterol concentrations, and plasma activities of alanine transaminase and aspartate transaminase. <i<S. filiforme</i< supplementation modulated gut microbiota without changing the Firmicutes to Bacteroidetes ratio. <i<S. filiforme</i< improved symptoms of high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. Possible mechanisms include a reduced infiltration of inflammatory cells into organs as well as prebiotic actions in the gastrointestinal tract.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">algae</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a"><i<sarconema filiforme</i<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">sulfated polysaccharides</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a"><i<ι</i<-carrageenan</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">prebiotics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">gut microbiota</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">aquaculture</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">nutraceutical</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Biology (General)</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Nicholas Paul</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Peter Mouatt</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Marwan E. Majzoub</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Torsten Thomas</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sunil K. Panchal</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Lindsay Brown</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Marine Drugs</subfield><subfield code="d">MDPI AG, 2005</subfield><subfield code="g">18(2020), 2, p 97</subfield><subfield code="w">(DE-627)477992420</subfield><subfield code="w">(DE-600)2175190-0</subfield><subfield code="x">16603397</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:18</subfield><subfield code="g">year:2020</subfield><subfield code="g">number:2, p 97</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3390/md18020097</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/8926b0591a054c76b0c309b8996523c0</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.mdpi.com/1660-3397/18/2/97</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1660-3397</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_381</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2147</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2148</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">18</subfield><subfield code="j">2020</subfield><subfield code="e">2, p 97</subfield></datafield></record></collection>
|
score |
7.401224 |